23andMe Holding Profit Margin

23andMe Holding (ME) currently reports a profit margin of -1.35% as of June 2025. That compares with -3.17% in the prior-year period — up 57.6% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore 23andMe Holding's profit margin history and peer comparisons.

23andMe Holding's profit margin increased from -3.17% to -1.35% — a 57.6% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

23andMe Holding's profit margin of -1.35% is lower than the Healthcare sector average of 15.58%. That is roughly 963.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but 23andMe Holding's current -1.35% should be judged against Healthcare norms (sector average: 15.58%) and against ME's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1.35%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for 23andMe Holding, and consider following ME for alerts when major investors trade the stock.